Literature DB >> 27624383

Overexpression of miR-140 Inhibits Proliferation of Osteosarcoma Cells via Suppression of Histone Deacetylase 4.

Qianren Xiao1, Lu Huang, Zhongzu Zhang, Xiang Chen, Jiaquan Luo, Zhanmin Zhang, Shaoqing Chen, Yong Shu, Zhimin Han, Kai Cao.   

Abstract

miRNAs play a pivotal role in the development and progression of osteosarcoma (OS). Previous studies indicated that miR-140 acts as a tumor suppressor in many cancers. However, its accurate expression and exact function in OS cells remain unknown. Herein, we demonstrated the lower expression of miR-140 in 40 paired OS tissues. Restoring miR-140 expression in OS cells had a marked effect on inhibiting cell proliferation and invasion, inducing cell apoptosis in vitro, and suppressing tumor growth in vivo. Moreover, a bioinformatics prediction indicated that the histone deacetylase 4 (HDAC4) is a target gene of miR-140 and is involved in miR-140-mediated suppressive effects. In conclusion, our findings show that miR-140 acts as a tumor suppressor in OS by targeting HDAC4.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27624383     DOI: 10.3727/096504016X14732510786564

Source DB:  PubMed          Journal:  Oncol Res        ISSN: 0965-0407            Impact factor:   5.574


  12 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

2.  MIR145-3p promotes autophagy and enhances bortezomib sensitivity in multiple myeloma by targeting HDAC4.

Authors:  Hongkun Wu; Chang Liu; Qingyuan Yang; Chengde Xin; Juan Du; Fenyong Sun; Lin Zhou
Journal:  Autophagy       Date:  2019-07-04       Impact factor: 16.016

3.  Knockdown of CircCRIM1 Inhibits HDAC4 to Impede Osteosarcoma Proliferation, Migration, and Invasion and Facilitate Autophagy by Targeting miR-432-5p.

Authors:  Jun Liu; Guang Feng; Zhengwei Li; Rui Li; Peng Xia
Journal:  Cancer Manag Res       Date:  2020-10-15       Impact factor: 3.989

Review 4.  The role of histone deacetylase 4 during chondrocyte hypertrophy and endochondral bone development.

Authors:  Zhi Chen; Zhiwei Zhang; Li Guo; Xiaochun Wei; Yang Zhang; Xiaojian Wang; Lei Wei
Journal:  Bone Joint Res       Date:  2020-05-16       Impact factor: 5.853

5.  Long noncoding RNA MALAT1 regulates HDAC4-mediated proliferation and apoptosis via decoying of miR-140-5p in osteosarcoma cells.

Authors:  Yuxiu Sun; Baoli Qin
Journal:  Cancer Med       Date:  2018-08-09       Impact factor: 4.452

6.  Prognosis Analysis of Histone Deacetylases mRNA Expression in Ovarian Cancer Patients.

Authors:  Lulu Zhou; Xiaohui Xu; Hailing Liu; Xiaoli Hu; Wenwen Zhang; Miaomiao Ye; Xueqiong Zhu
Journal:  J Cancer       Date:  2018-11-11       Impact factor: 4.207

7.  MicroRNA-140-5p regulates the proliferation, apoptosis and inflammation of RA FLSs by repressing STAT3.

Authors:  Jiehua Zhu; Jianglin Wang; Jialin Huang; Wensheng Du; Yingzhong He; Hongfei Pan; Junmin Luo
Journal:  Exp Ther Med       Date:  2020-12-27       Impact factor: 2.447

8.  miR-140 inhibits osteosarcoma progression by impairing USP22-mediated LSD1 stabilization and promoting p21 expression.

Authors:  Wei Liu; Dunwei Wang; Lidi Liu; Lin Wang; Ming Yan
Journal:  Mol Ther Nucleic Acids       Date:  2021-02-03       Impact factor: 8.886

Review 9.  Biology and pathogenesis of human osteosarcoma.

Authors:  Judson Welber Veríssimo de Azevedo; Thales Allyrio Araújo de Medeiros Fernandes; José Veríssimo Fernandes; Jenner Chrystian Veríssimo de Azevedo; Daniel Carlos Ferreira Lanza; Christiane Medeiros Bezerra; Vânia Sousa Andrade; Josélio Maria Galvão de Araújo; José Veríssimo Fernandes
Journal:  Oncol Lett       Date:  2019-12-18       Impact factor: 2.967

10.  Long non-coding RNA PGM5-AS1 promotes epithelial-mesenchymal transition, invasion and metastasis of osteosarcoma cells by impairing miR-140-5p-mediated FBN1 inhibition.

Authors:  Wei Liu; Pengcheng Liu; Hang Gao; Xu Wang; Ming Yan
Journal:  Mol Oncol       Date:  2020-08-19       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.